EDAP TMS EDAP 深 滬
已收盤 07-25 16:00:00 美东时间
1.40
-0.030
-2.10%
華盛通- 最 高1.4599
- 今 開1.43
- 成交量 1.99万股
- 最 低 1.40
- 昨 收 1.43
- 總市值 5234.89万
- 52周最高 4.9252
- 市盈率 靜 --
- 換手率 0.05%
- 52周最低 1.26
- 委 比 83.42%
- 總股本 3739.21万
- 歷史最高 12.65
- 量 比 0.30
- 振 幅 4.19%
- 歷史最低 1.15
- 每 手 1
- 風險率 1.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多EDAP TMS Announces Transition to U.S. Domestic Filer Status
EDAP TMS ( ($EDAP) ) just unveiled an announcement. On July 1, 2025, EDAP TMS a...
07-01 19:51
EDAP TMS Will No Longer Qualify as Foreign Issuer, Adopts US Reporting Rules
EDAP TMS SA (NASDAQ:EDAP) ("the Company" or "EDAP"), the global leader in robotic energy-based therapies, announced a change in its U.S. reporting status. EDAP TMS S.A. (the "Company") currently qualifies as a foreign
07-01 19:06
EDAP Announces Transition from Foreign Private Issuer to U.S. Domestic Filer Status
EDAP TMS SA, a global leader in robotic energy-based therapies, announced it will transition from foreign private issuer to U.S. domestic filer status effective January 1, 2026. This change will require the company to comply with SEC and Nasdaq rules for U.S. domestic issuers, including board composition and corporate governance. CEO Ryan Rhodes emphasized the move reflects long-term commitment to transparency, regulatory practices, and expanding...
07-01 11:00
EDAP to Present at the Jefferies Global Healthcare Conference
EDAP TMS SA, a global leader in robotic energy-based therapies, announced that its CEO, Ryan Rhodes, will present and host investor meetings at the Jefferies Global Healthcare Conference in New York on June 3-5, 2025. His presentation is scheduled for June 5 at 4:20-4:50 PM ET. The live and archived webcast will be available via the provided link. EDAP TMS specializes in minimally invasive medical devices using ultrasound technology, notably the ...
05-27 11:00
EDAP TMS S.A. misses top-line and bottom-line estimates; reaffirms FY25 outlook
EDAP TMS S.A. press release (NASDAQ:EDAP): Q1 GAAP EPS of -$0.19 misses by $0.03. Revenue of $14.3M (-11.2% Y/Y) misses by $2.26M. As of March 31, 2025, the company held cash and cash equivalents of E...
05-15 19:14
Edap TMS Q1 EPS $(0.20) Misses $(0.15) Estimate, Sales $14.28M Miss $14.90M Estimate
Edap TMS (NASDAQ:EDAP) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.15) by 33.33 percent. This is a 53.85 percent decrease over losses of $(0.13) per share from the
05-15 19:07
Earnings Scheduled For May 15, 2025
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is expected t...
05-15 16:32
EDAP TMS S.A. Q1 2025 Earnings Preview
EDAP TMS S.A. (NASDAQ:EDAP) is scheduled to announce Q1 earnings results on Thursday, May 15th, before market open. The consensus EPS Estimate is -$0.17 and the consensus Revenue Estimate is $16.56M. ...
05-14 23:52
美股大行评级 | 潜在涨幅1543.84%！Compass Therapeutics获HC Wainwright升目标价至24美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1115197988923084800.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Compass Therapeutics(CMPX)"买入"评级，目标价从10美元升至24美元</p> <p>• 瑞杰金融：维持Freeport-McMoRan(FCX)
04-07 10:45
美股大行评级 | 潜在涨幅686.94%！Sensei Biotherapeutics获Oppenheimer升目标价至4美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1112661771769712640.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer：维持Sensei Biotherapeutics(SNSE)"跑赢大市"评级，目标价从3.5美元升至4美元</p> <p>• 富国银行：上调Regulus Therapeutics(RGLS)评级至
03-29 18:13
